Patent Assignment
Reel/Frame 047782/0163
Assignment of Assignor's Interest
Recorded: 2018-12-14
Pages: 4
Assignor
REGEN BIOPHARMA, INC.
Executed: 2018-12-14
Assignee
KCL THERAPEUTICS, INC
4700 SPRING ST., SUITE 304, LA MESA, CALIFORNIA, 91942
Covered Properties
(5)
Small Molecule Modulators of NR2F6 Activity
Application:
62/363,588 →
Small Molecule Modulators of NR2F6 Activity
Application:
15/652,967 →
Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans
Small Molecule Agonists and Antagonists of NR2F6 Activity
NR2F6 Inhibited Chimeric Antigen Receptor Cells
Application:
15/351,414 →
Publication:
US 2021/0317180
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 22, 2016
From: KOOS, DAVID; LANDER, HARRY
To: REGEN BIOPHARMA, INC.
Reel/Frame 039218/0438 →
Assignment of Assignor's Interest
Aug 16, 2017
From: KOOS, DAVID; LANDER, HARRY
To: REGEN BIOPHARMA, INC.
Reel/Frame 043309/0082 →
Assignment of Assignor's Interest
Nov 28, 2017
From: LANDER, HARRY M.; KOOS, DAVID R.
To: REGEN BIOPHARMA INC.
Reel/Frame 044234/0578 →
Assignment of Assignor's Interest
Aug 8, 2018
From: LANDER, HARRY M.; KOOS, DAVID R.
To: REGEN BIOPHARMA INC.
Reel/Frame 046590/0115 →
Assignment of Assignor's Interest
Dec 14, 2018
From: ICHIM, THOMAS; KOOS, DAVID
To: REGEN BIOPHARMA
Reel/Frame 047780/0891 →
Assignment of Assignor's Interest
Jul 9, 2019
From: KCL THERAPEUTICS, INC.
To: ZANDER THERAPEUTICS, INC.
Reel/Frame 049704/0669 →
Assignment of Assignor's Interest
Feb 28, 2022
From: ZANDER THERAPEUTICS INC.
To: ZANDER BIOLOGICS INC.
Reel/Frame 059121/0909 →
Assignment of Assignor's Interest
Jul 19, 2023
From: ZANDER BIOLOGICS, INC.
To: SYBLEU INC.
Reel/Frame 064319/0263 →